<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35320398</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100&#xa0;years.</ArticleTitle><Pagination><StartPage>4030</StartPage><EndPage>4054</EndPage><MedlinePgn>4030-4054</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11073-3</ELocationID><Abstract><AbstractText>Frontotemporal lobar degeneration (FTLD) with TDP-43-immunoreactive inclusions (FTLD-TDP) is a neurodegenerative disease associated with clinical, genetic, and neuropathological heterogeneity. An association between TDP-43, FTLD and amyotrophic lateral sclerosis (ALS) was first described in 2006. However, a century before immunohistochemistry existed, atypical dementias displaying behavioral, language and/or pyramidal symptoms and showing non-specific FTLD with superficial cortical neuronal loss, gliosis and spongiosis were often confused with Alzheimer's or Pick's disease. Initially this pathology was termed dementia lacking distinctive histopathology (DLDH), but this was later renamed when ubiquitinated inclusions originally found in ALS were also discovered in (DLDH), thus warranting a recategorization as FTLD-U (ubiquitin). Finally, the ubiquitinated protein was identified as TDP-43, which aggregates in cortical, subcortical, limbic and brainstem neurons and glial cells. The topography and morphology of TDP-43 inclusions associate with specific clinical syndromes and genetic mutations which implies different pathomechanisms that are yet to be discovered; hence, the TDP-43 journey has actually just begun. In this review, we describe how FTLD-TDP was established and defined clinically and neuropathologically throughout the past century.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carlos</LastName><ForeName>Arenn F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-2100-5033</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 1st St S.W, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Josephs</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0003-2930-8634</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 1st St S.W, Rochester, MN, 55905, USA. josephs.keith@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG037491</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS120992</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DLDH</Keyword><Keyword MajorTopicYN="N">FTLD-U</Keyword><Keyword MajorTopicYN="N">FTLD&#x2013;TDP</Keyword><Keyword MajorTopicYN="N">Frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">Hippocampal sclerosis</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>Competing interests: The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35320398</ArticleId><ArticleId IdType="mid">NIHMS1891599</ArticleId><ArticleId IdType="pmc">PMC10184567</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11073-3</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11073-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Onari K, Spatz H (1926) Anatomische Beitr&#xe4;ge zur Lehre von der Pickschen umschriebenen Gro&#xdf;hirnrinden-Atrophie (&#x201c;Picksche Krankheit&#x201d;) [Anatomical contributions to the theory of Pick&#x2019;s circumscribed cerebral cortex atrophy (Pick&#x2019;s disease]. Z Ges Neurol Psychiat 101:470&#x2013;511</Citation></Reference><Reference><Citation>McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick&#x2019;s Disease. Arch Neurol 58:1803&#x2013;1809</Citation><ArticleIdList><ArticleId IdType="pubmed">11708987</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3232515</ArticleId><ArticleId IdType="pubmed">21614463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5&#x2019;-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702&#x2013;705</Citation><ArticleIdList><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205&#x2013;1208</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546&#x2013;1554</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J, Neary D, Mann D (2007) Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 114:31&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">17569065</ArticleId></ArticleIdList></Reference><Reference><Citation>Pick A (1892) &#xdc;ber die Beziehungen der senilen Hirnatrophie zur Aphasie [The relation between senile brain atrophy and aphasia]. Prag Med Wochenschr 17:165&#x2013;167</Citation></Reference><Reference><Citation>Pick A (1901) Senile Hirnatrophie als Grundlage von Herderscheinungen [Senile brain atrophy as the basis of focal symptoms]. Wien Klin Wochenschr 14:403&#x2013;404</Citation></Reference><Reference><Citation>Pick A (1904) Zur Symptomatologie der linksseitigen Schl&#xe4;fenlappenatrophie [On the symptomatology of left-sided temporal lobe atrophy]. Monatsschr Psychiatr Neurol 16:378&#x2013;388</Citation></Reference><Reference><Citation>Pick A (1904) &#xdc;ber prim&#xe4;re progressive Demenz bei Erwachsenen [On primary progressive dementia of adults]. Prag Med Wochenschr 29:417&#x2013;420</Citation></Reference><Reference><Citation>Pick A (1906) &#xdc;ber einen weiteren symptomencomplex in Rahmen des Dementia senilis, bedingt durch umschriebene str&#xe4;kere Hirnatrophie (gemischte Apraxie) [About another complex of symptoms in the context of dementia senilis, caused by circumscribed severe cerebral atrophy (mixed apraxia)]. Monatsschr Psychiatr Neurol 19:97&#x2013;108</Citation></Reference><Reference><Citation>Pick A, Girling DM, Berrios GE (1994) On the relationship between senile cerebral atrophy and aphasia History of Psychiatry 5:542&#x2013;547</Citation></Reference><Reference><Citation>Pick A, Girling DM, Markova IS (1995) Senile Hirnatrophie als Grundlage von Herderscheinungen. [Senile cerebral atrophy as the origin of focal symptoms.] Hist Psychiatry 6:533&#x2013;537</Citation></Reference><Reference><Citation>Pick A, Girling DM, Berrios GE (1997) On the symptomatology of left-sided temporal lobe atrophy History of Psychiatry 8:149&#x2013;159</Citation><ArticleIdList><ArticleId IdType="pubmed">11619205</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion S, Plas J, Jeanneau A (1991) [Pick&#x2019;s disease. Anatomo-clinical point of view]. Rev Neurol (Paris) 147:693&#x2013;704</Citation><ArticleIdList><ArticleId IdType="pubmed">1775822</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM (1982) Slowly progressive aphasia without generalized dementia. Ann Neurol 11:592&#x2013;598</Citation><ArticleIdList><ArticleId IdType="pubmed">7114808</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeck K, Luzzatti C (1988) Slowly progressive aphasia in three patients. The problem of accompanying neuropsychological deficit. Brain 111 (Pt 1):151&#x2013;168</Citation><ArticleIdList><ArticleId IdType="pubmed">3365545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz A, Davidson W, McCabe P (1998) Primary progressive semantic aphasia: a case study. J Int Neuropsychol Soc 4:388&#x2013;398</Citation><ArticleIdList><ArticleId IdType="pubmed">9656612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges JR, Patterson K, Oxbury S, Funnell E (1992) Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 115 (Pt 6):1783&#x2013;1806</Citation><ArticleIdList><ArticleId IdType="pubmed">1486461</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatt J (2003) Arnold Pick&#x2019;s concept of dementia. Cortex 39:525&#x2013;531</Citation><ArticleIdList><ArticleId IdType="pubmed">12870825</ArticleId></ArticleIdList></Reference><Reference><Citation>Derouesne C (2014) [From Arnold Pick&#x2019;s original descriptions to frontotemporal dementia: the present enlightened by the past an historical approach]. Geriatr Psychol Neuropsychiatr Vieil 12:74&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pubmed">24647241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertesz A (2004) Frontotemporal dementia/Pick&#x2019;s disease. Arch Neurol 61:969&#x2013;971</Citation><ArticleIdList><ArticleId IdType="pubmed">15210543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gans A (1923) Betrachtungen &#xfc;ber Art und Ausbreitung des krankhaften Prozesses in einem Fall von Pickscher Atrophie des Stirnhirns [Reflections on the nature and spread of the disease process in a case of Pick&#x2019;s atrophy of the frontal lobe]. Z Ges Neurol Psychiat 80:10&#x2013;28</Citation></Reference><Reference><Citation>Alzheimer A (1911) &#xdc;ber eigenartige Krankheitsf&#xe4;lle des sp&#xe4;teren Alters [On certain peculiar diseases of old age]. Z Ges Neurol Psychiat 4:356&#x2013;385</Citation></Reference><Reference><Citation>Alzheimer A (1991) &#xdc;ber eigenartige Krankheitsf&#xe4;lle des sp&#xe4;teren Alters: (On certain peculiar diseases of old age). . History of Psychiatry 2:74&#x2013;101</Citation><ArticleIdList><ArticleId IdType="pubmed">11622845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW (2001) Neuropathology of Pick&#x2019;s disease. Neurology 56:S16&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">11402145</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C (1927) &#xdc;eber Picksche Krankheit. [Pick&#x2019;s disease]. . Monatsschr Psychiatr Neurol 65:230&#x2013;275.</Citation></Reference><Reference><Citation>Schneider C (1929) Weitere Beitr&#xe4;ge zur Lehre von der Pickschen Krankheit [Further contributions to the theory of Pick&#x2019;s disease]. Z Ges Neurol Psychiat 120:340&#x2013;384</Citation></Reference><Reference><Citation>Gr&#xfc;nthal E (1930) &#xdc;ber ein Br&#xfc;derpaar mit Pickscher Krankheit: Eine vergleichende Untersuchung, zugleich ein Beitrag zur Kenntnis der Verursachung und des Verlaufs der Erkrankung. [Two brothers with Pick&#x2019;s disease: A comparative study and contribution to the knowledge of the cause and the course of the disease.]. Z Ges Neurol Psychiat 129:350&#x2013;375</Citation></Reference><Reference><Citation>v. Braunm&#xfc;hl A, Leonhard K (1934) &#xdc;ber ein Schwesternpaar mit Pickscher Krankheit [On a pair of sisters with Pick&#x2019;s disease]. Z Ges Neurol Psychiat 150:209&#x2013;241</Citation></Reference><Reference><Citation>Verhaart WJC (1930) Over de ziekte van Pick [About Pick&#x2019;s disease]. Nederl Tijdschr Geneesk 74:5586&#x2013;5598</Citation></Reference><Reference><Citation>Malamud N, Waggoner RW (1943) Genealogic and clinicopathologic study of Pick&#x2019;s disease. Arch Neurol Psychiat 50:288&#x2013;303</Citation></Reference><Reference><Citation>Keddie KM (1967) Presenile dementia, clinically of the Pick&#x2019;s disease variety, occurring in a mother and daughter. International Journal of Neuropsychiatry, 3:182&#x2013;187</Citation><ArticleIdList><ArticleId IdType="pubmed">6029993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro A, Jervis A (1936) Pick&#x2019;s disease: Clinicopathologic study with report of two cases. Arch NeurPsych 36:739&#x2013;767</Citation></Reference><Reference><Citation>Delay J, Brion S, Escourolle R (1957) Limites et conception actuelle de la maladie de Pick : son diagnostic diff&#xe9;rentiel [Limits &amp; current concept of Pick&#x2019;s disease; its differential diagnosis]. Ann Med Psychol (Paris) 115:609&#x2013;634</Citation><ArticleIdList><ArticleId IdType="pubmed">13425127</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibodeau MP, Miller BL (2013) &#x2018;Limits and current knowledge of Pick&#x2019;s disease: its differential diagnosis&#x2019;. A translation of the 1957 Delay, Brion, Escourolle article. Neurocase 19:417&#x2013;422</Citation><ArticleIdList><ArticleId IdType="pubmed">22554132</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann MA (1949) Pick&#x2019;s disease. Journal of Neuropathology &amp; Experimental Neurology 8:255&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">18153924</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassin GB, Levitin D (1941) Pick&#x2019;s disease: clinicopathologic study and report of a case. Arch NeurPsych 45:814&#x2013;833</Citation></Reference><Reference><Citation>L&#xf6;wenberg K (1936) Pick&#x2019;s disease: A clinicopathologic contribution. Archives of Neurology &amp; Psychiatry 36:768&#x2013;789</Citation></Reference><Reference><Citation>Kahn E, Thompson LJ (1934) Concerning Pick&#x2019;s disease. Am J Psychiatry 90:937&#x2013;946</Citation></Reference><Reference><Citation>Stern K, Reed GE (1945) Presenile dementia (Alzheimer&#x2019;s disease). Am J Psychiatry 102:191&#x2013;197</Citation></Reference><Reference><Citation>Marchand L, Anglade R, Fretet J, Rougean M, Roan P (1938) La maladie de Pick, la maladie d&#x2019;Alzheimer, et la d&#xe9;mence s&#xe9;nile sans ath&#xe9;rome c&#xe9;r&#xe9;bral sont-elles les trois modalit&#xe9;s d&#x2019;un m&#xea;me processus d&#xe9;g&#xe9;n&#xe9;ratif [Are Pick&#x2019;s disease, Alzheimer&#x2019;s disease and senile dementia without atherosclerosis all the same degenerative process]. Ann Med Psychol (Paris) 96:249&#x2013;255</Citation></Reference><Reference><Citation>Marchand L (1937) La d&#xe9;mence s&#xe9;nile sans atherome c&#xe9;r&#xe9;bral. Ses rapports avec la maladie d&#x2019;Alzheimer et la maladie de Pick. Considerations sur les encephaloses [Senile dementia without atherosclerosis; Its relation with Alzheimer&#x2019;s and Pick&#x2019;s disease. Considerations on encephalosis]. Ann Med Psychol (Paris) 95:680&#x2013;735</Citation></Reference><Reference><Citation>Delay J, Brion S, Badaracco JC (1955) Le diagnostic diff&#xe9;rentiel des maladies de Pick et d&#x2019;Alzhiemer (A propos de 12 observations anatomo-cliniques) [Differential diagnosis of Pick&#x2019;s disease from Alzheimer&#x2019;s disease; anatomical and clinical observations on 12 cases]. Encephale 44:454&#x2013;499</Citation><ArticleIdList><ArticleId IdType="pubmed">13305504</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatz H (1952) La maladie de Pick les atrophies syst&#xe9;matis&#xe9;es progressives et la s&#xe9;nescence c&#xe9;r&#xe9;brale pr&#xe9;matur&#xe9;e localis&#xe9;e. 1er congres international d&#x2019;histopathologie du syst&#xe8;me nerveux [Pick&#x2019;s disease, progressive atrophy and premature localized cerebral senescence. 1st international conference on nervous system histopathology] 2:375&#x2013;406</Citation></Reference><Reference><Citation>Escourolle R (1956) La maladie de Pick. Etude d&#x2019;ensemble et synth&#xe8;se anatomo-clinique [Pick&#x2019;s disease: critical study and anatomo-clinical summary]. In:Dissertation, Paris</Citation></Reference><Reference><Citation>Rewcastle NB, Ball MJ (1968) Electron microscopic structure of the &#x201c;inclusion bodies&#x201d; in Pick&#x2019;s disease. Neurology 18:1205&#x2013;1213</Citation><ArticleIdList><ArticleId IdType="pubmed">4178657</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion S, Mikol J (1971) [Ultrastructural study of Pick&#x2019;s disease. Apropos of 3 cases]. Rev Neurol (Paris) 125:273&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pubmed">4340948</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion S, Mikol J, Psimaras A (1973) Recent findings in Pick&#x2019;s Disease. In: Zimmerman HM (ed) Progress in neuropathology. Grune and Stratton, New York, pp 421&#x2013;452</Citation></Reference><Reference><Citation>Constantinidis J, Richard J, Tissot R (1974) Pick&#x2019;s disease. Histological and clinical correlations. Eur Neurol 11:208&#x2013;217</Citation><ArticleIdList><ArticleId IdType="pubmed">4137107</ArticleId></ArticleIdList></Reference><Reference><Citation>Papageorgiou SG, Beratis IN, Horvath J, Herrmann FR, Bouras C, K&#xf6;vari E (2016) Amnesia in frontotemporal dementia: shedding light on the Geneva historical data. J Neurol 263:657&#x2013;664</Citation><ArticleIdList><ArticleId IdType="pubmed">26810723</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion S (1977) Les demences preseniles [Presenile dementias]. In: Encycl. Med. Chir. 37 545, A10, Paris, pp 1&#x2013;16</Citation></Reference><Reference><Citation>Masse G, Mikol J, Brion S (1981) Atypical presenile dementia: Report of an anatomo-clinical case and review of the literature. J Neurol Sci 52:245&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pubmed">7310435</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A, Gustafson L (1978) Limbic lobe involvement in presenile dementia. Arch Psychiatr Nervenkr (1970) 226:79&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">367312</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer&#x2019;s disease. A clinico-pathological study. Arch Psychiatr Nervenkr (1970) 223:15&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">828039</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann MA, Cohn R (1967) Progressive subcortical gliosis, a rare form of presenile dementia. Brain 90:405&#x2013;418</Citation><ArticleIdList><ArticleId IdType="pubmed">5339109</ArticleId></ArticleIdList></Reference><Reference><Citation>Akelaitis AJ (1944) Atrophy of Basal Ganglia in Pick&#x2019;s Disease. Clinicopathologic study. Arch Neurol Psychiatr 51:27&#x2013;34</Citation></Reference><Reference><Citation>Kim RC, Collins GH, Parisi JE, Wright AW, Chu YB (1981) Familial dementia of adult onset with pathological findings of a &#x2018;non-specific&#x2019; nature. Brain 104:61&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pubmed">7470845</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaumburg HH, Suzuki K (1968) Non-specific familial presenile dementia. J Neurol Neurosurg Psychiatr 31:479&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pmc">PMC496404</ArticleId><ArticleId IdType="pubmed">5709832</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark AW, White CL, Manz HJ, Parhad IM, Curry B, Whitehouse PJ, Lehmann J, Coyle JT (1986) Primary Degenerative Dementia Without Alzheimer Pathology. Can J Neurol Sci 13:462&#x2013;470</Citation><ArticleIdList><ArticleId IdType="pubmed">3791063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CP, Myers FK, Smith K, Torack RM (1973) Nosologic problems in dementia. A clinical and pathologic study of 11 cases. Neurology 23:344&#x2013;351</Citation><ArticleIdList><ArticleId IdType="pubmed">4736122</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Cole M, Banker BQ, Wright D (1984) Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 16:455&#x2013;466</Citation><ArticleIdList><ArticleId IdType="pubmed">6497355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole M, Wright D, Banker BQ (1979) Familial aphasia due to Pick&#x2019;s disease. Ann Neurol 6:158</Citation></Reference><Reference><Citation>Cole M, Wright D, Banker BQ (1979) Familial aphasia: the Pick-Alzheimer spectrum. Trans Am Neurol Assoc 104:175&#x2013;179</Citation><ArticleIdList><ArticleId IdType="pubmed">553401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lendon CL, Lynch T, Norton J, McKeel DW Jr, Busfield F, Craddock N, Chakraverty S, Gopalakrishnan G, Shears SD, Grimmett W, Wilhelmsen KC, Hansen L, Morris JC, Goaste AM (1998) Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21&#x2013;22. Neurology 50:1546&#x2013;1555</Citation><ArticleIdList><ArticleId IdType="pubmed">9633693</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, Carter D, Paulsmeyer K, Taylor-Reinwald L, Gitcho M, Norton JB, Chakraverty S, Goate AM, Morris JC, Cairns NJ (2007) Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord 21:1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">17334266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehler MF, Horoupian DS, Davies P, Dickson DW (1987) Reduced somatostatin-like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia. Neurology 37:1448&#x2013;1453</Citation><ArticleIdList><ArticleId IdType="pubmed">2888051</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejerine J, Serieux P (1897) Un cas de surdit&#xe9; verbale pure, termin&#xe9;e par aphasie sensorielle, suivi d&#x2019;autopsie [A case of pure word deafness terminating in sensory aphasia, followed by autopsy]. C R Soc Biol (Paris) 49:1074&#x2013;1077</Citation></Reference><Reference><Citation>Heath PD, Kennedy P, Kapur N (1983) Slowly progressive aphasia without generalized dementia. Ann Neurol 13:687&#x2013;688</Citation><ArticleIdList><ArticleId IdType="pubmed">6881935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawluk JB, Mesulam MM, Hurtig H, Kushner M, Weintraub S, Saykin A, Rubin N, Alavi A, Reivich M (1986) Slowly progressive aphasia without generalized dementia: studies with positron emission tomography. Ann Neurol 19:68&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">3484931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshner HS, Webb WG, Kelly MP, Wells CE (1984) Language disturbance. An initial symptom of cortical degenerations and dementia. Arch Neurol 41:491&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pubmed">6721714</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM, Weintraub S (1992) Spectrum of primary progressive aphasia. Baillieres Clin Neurol 1:583&#x2013;609</Citation><ArticleIdList><ArticleId IdType="pubmed">1344204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM (2001) Primary progressive aphasia. Ann Neurol 49:425&#x2013;432</Citation><ArticleIdList><ArticleId IdType="pubmed">11310619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM (1987) Primary progressive aphasia--differentiation from Alzheimer&#x2019;s disease. Ann Neurol 22:533&#x2013;534</Citation><ArticleIdList><ArticleId IdType="pubmed">3324947</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Neary D, Mann DM, Goulding PJ, Testa HJ (1992) Progressive language disorder due to lobar atrophy. Ann Neurol 31:174&#x2013;183</Citation><ArticleIdList><ArticleId IdType="pubmed">1575456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshner HS, Tanridag O, Thurman L, Whetsell WO Jr. (1987) Progressive aphasia without dementia: two cases with focal spongiform degeneration. Ann Neurol 22:527&#x2013;532</Citation><ArticleIdList><ArticleId IdType="pubmed">3435071</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Morris JC, Sandson J, McKeel DW Jr, Miller JW (1990) Progressive aphasia: a precursor of global dementia? Neurology 40:423&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">2314582</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrington EK (1975) The selective impairment of semantic memory. Q J Exp Psychol 27:635&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">1197619</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J, Goulding P, Neary D (1989) Semantic Dementia: a form of circumscribed cerebral atrophy. Behav Neurol 2:167&#x2013;182</Citation></Reference><Reference><Citation>Neary D, Snowden JS, Northen B, Goulding P (1988) Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 51:353&#x2013;361</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1032860</ArticleId><ArticleId IdType="pubmed">3258902</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP (2001) How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol 58:512&#x2013;515</Citation><ArticleIdList><ArticleId IdType="pubmed">11255459</ArticleId></ArticleIdList></Reference><Reference><Citation>Androp S (1940) Amyotrophic lateral sclerosis with psychosis. Psychiatric Quarterly 14:818&#x2013;825</Citation></Reference><Reference><Citation>Ziegler LH (1930) Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry 24:930&#x2013;936</Citation></Reference><Reference><Citation>Westphal A (1925) Schizophrene Krankheitsprozesse und amyotrophische Lateralsklerose [Schizophrenic disease processes and amyotrophic lateral sclerosis]. Arch Psychiat Nervenkr 74:310&#x2013;325</Citation></Reference><Reference><Citation>Wechsler IS, Davison C (1932) Amyotrophic lateral sclerosis with mental symptoms. Arch Neurol Psychiatr 27:859&#x2013;880</Citation></Reference><Reference><Citation>Meyer A (1929) &#xdc;ber eine der amyotrophischen Lateralsklerose nahestehende Erkrankung mit psychischen St&#xf6;rungen [About a disease related to amyotrophic lateral sclerosis with mental disorders]. Z Ges Neurol Psychiat 121:107&#x2013;138</Citation></Reference><Reference><Citation>v. Bagh K (1941) &#xdc;ber anatomische Befunde bei 30 F&#xe4;llen von systematischer Atrophie der Gro&#xdf;hirnrinde (Pickscher Krankheit) mit besonderer Ber&#xfc;cksichtigung der Stammganglien und der langen absteigenden Leitungsbahnen. Eine vorl&#xe4;ufige Mitteilung [Anatomic findings in 30 cases of systemic atrophy of the cerebral cortex (Pick&#x2019;s disease) with particular attention to the basal ganglia and the long descending pathways. A preliminary communication]. Arch Psychiat Nervenkr 114:68&#x2013;70</Citation></Reference><Reference><Citation>Hirano A, Kurland LT, Krooth RS, Lessell S (1961) Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain 84:642&#x2013;661</Citation><ArticleIdList><ArticleId IdType="pubmed">13907609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonduelle M, Bouygues P, Escourolle R, Lormeau G (1968) [Simultaneous development of amyotrophic lateral sclerosis, Parkinson&#x2019;s syndrome and progressive dementia. Apropos of 2 anatomoclinical cases. Attempted interpretation]. J Neurol Sci 6:315&#x2013;332</Citation><ArticleIdList><ArticleId IdType="pubmed">5707430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuyama Y, Takamiya S (1979) Presenile dementia with motor neuron disease in Japan. A new entity? Arch Neurol 36:592&#x2013;593</Citation><ArticleIdList><ArticleId IdType="pubmed">475629</ArticleId></ArticleIdList></Reference><Reference><Citation>Horoupian DS, Thal L, Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J, et al. (1984) Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Ann Neurol 16:305&#x2013;313</Citation><ArticleIdList><ArticleId IdType="pubmed">6148912</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Mann DM, Northen B, Goulding PJ, Macdermott N (1990) Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 53:23&#x2013;32</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1014093</ArticleId><ArticleId IdType="pubmed">2303828</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden J, Mann D (2005) Frontotemporal dementia. Lancet Neurol 4:771&#x2013;780</Citation><ArticleIdList><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, Kaiya H, Ikeda T, Namba M (1987) Presenile dementia combined with amyotrophy: a review of 34 Japanese cases. Arch Gerontol Geriatr 6:263&#x2013;277</Citation><ArticleIdList><ArticleId IdType="pubmed">3318745</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar AM, Masters CL, Gajdusek DC, Gibbs CJ Jr. (1983) Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann Neurol 14:17&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">6351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A (2007) Identification and characterization of frontal lobe degeneration: historical perspective on the development of FTD. Alzheimer Dis Assoc Disord 21:S3&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pubmed">18090420</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Bowen DM, Sims NR, Mann DM, Benton JS, Northen B, Yates PO, Davison AN (1986) Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 49:163&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1028682</ArticleId><ArticleId IdType="pubmed">2419511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson L (1987) Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6:209&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pubmed">3689054</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A (1987) Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 6:193&#x2013;208</Citation><ArticleIdList><ArticleId IdType="pubmed">3689053</ArticleId></ArticleIdList></Reference><Reference><Citation>Risberg J (1987) Frontal lobe degeneration of non-Alzheimer type. III. Regional cerebral blood flow. Arch Gerontol Geriatr 6:225&#x2013;233</Citation><ArticleIdList><ArticleId IdType="pubmed">3689055</ArticleId></ArticleIdList></Reference><Reference><Citation>Englund E, Brun A (1987) Frontal lobe degeneration of non-Alzheimer type. IV. White matter changes. Arch Gerontol Geriatr 6:235&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">3689056</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson L, Brun A, Passant U (1992) Frontal lobe degeneration of non-Alzheimer type. Baillieres Clin Neurol 1:559&#x2013;582</Citation><ArticleIdList><ArticleId IdType="pubmed">1344203</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A, Gustafson L (2011) The birth and early evolution of the frontotemporal dementia (FTD) concept. J Mol Neurosci 45:324&#x2013;329</Citation><ArticleIdList><ArticleId IdType="pubmed">21647707</ArticleId></ArticleIdList></Reference><Reference><Citation>Johanson A, Hagberg B (1989) Psychometric characteristics in patients with frontal lobe degeneration of non-Alzheimer type. Arch Gerontol Geriatr 8:129&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">2735785</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstl H, Hentschel F, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U, Bayerl JR, Schmitz F, Schmitt HP (1994) [Frontal and temporal onset of brain atrophy. Clinical and instrumental findings]. Nervenarzt 65:611&#x2013;618</Citation><ArticleIdList><ArticleId IdType="pubmed">7991007</ArticleId></ArticleIdList></Reference><Reference><Citation>Filley CM, Kleinschmidt-De Masters BK, Gross KF (1994) Non-Alzheimer fronto-temporal degenerative dementia. A neurobehavioral and pathologic study. Clin Neuropathol 13:109&#x2013;116</Citation><ArticleIdList><ArticleId IdType="pubmed">8088029</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Mastri AR, Frey WH 2nd, Sung JH, Rustan T (1990) Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 40:251&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pubmed">2300243</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS (1993) Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia. Dementia 4:132&#x2013;136</Citation><ArticleIdList><ArticleId IdType="pubmed">8401780</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, Mena I (1991) Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 41:1374&#x2013;1382</Citation><ArticleIdList><ArticleId IdType="pubmed">1891084</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson DF (1993) Progressive frontal dysfunction. Dementia 4:149&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pubmed">8401783</ArticleId></ArticleIdList></Reference><Reference><Citation>Risberg J, Passant U, Warkentin S, Gustafson L (1993) Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type. Dementia 4:186&#x2013;187</Citation><ArticleIdList><ArticleId IdType="pubmed">8401790</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BL, Chang L, Mena I, Boone K, Lesser IM (1993) Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia 4:204&#x2013;213</Citation><ArticleIdList><ArticleId IdType="pubmed">8401793</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland RP, Koss E, Lerner A, Hedera P, Ellis W, Dronkers N, Ober BA, Jagust WJ (1993) Functional imaging, the frontal lobes, and dementia. Dementia 4:192&#x2013;203</Citation><ArticleIdList><ArticleId IdType="pubmed">8401792</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Gydesen S, Sorensen SA, Brun A, Duff K, Houlden H, Fidani L, Kullkarni S, Cummings J, Goate A, et al. (1993) Exclusion mapping in familial non-specific dementia. Dementia 4:163&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pubmed">8401786</ArticleId></ArticleIdList></Reference><Reference><Citation>Edvinsson L, Minthon L, Ekman R, Gustafson L (1993) Neuropeptides in cerebrospinal fluid of patients with Alzheimer&#x2019;s disease and dementia with frontotemporal lobe degeneration. Dementia 4:167&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pubmed">8401787</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM (1993) Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 4:172&#x2013;177</Citation><ArticleIdList><ArticleId IdType="pubmed">8401788</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A (1993) Frontal lobe degeneration of non-Alzheimer type revisited. Dementia 4:126&#x2013;131</Citation><ArticleIdList><ArticleId IdType="pubmed">8401779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DM, South PW, Snowden JS, Neary D (1993) Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 56:605&#x2013;614</Citation><ArticleIdList><ArticleId IdType="pmc">PMC489608</ArticleId><ArticleId IdType="pubmed">8509772</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Brun A (1996) Regional and laminar synaptic pathology in frontal lobe degeneration of non-alzheimer type. Int J Geriatr Psychiatry 11:47&#x2013;55</Citation></Reference><Reference><Citation>Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer&#x2019;s disease and frontal lobe degeneration. Dementia 7:128&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">8740626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper PN, Jackson M, Lennox G, Lowe J, Mann DM (1995) Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 52:1011&#x2013;1015</Citation><ArticleIdList><ArticleId IdType="pubmed">7575218</ArticleId></ArticleIdList></Reference><Reference><Citation>Groups TLaM (1994) Clinical and neuropathological criteria for frontotemporal dementia. . J Neurol Neurosurg Psychiatry 57:416&#x2013;418</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1072868</ArticleId><ArticleId IdType="pubmed">8163988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Kouri N, Murray ME, Josephs KA (2011) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384&#x2013;389</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208128</ArticleId><ArticleId IdType="pubmed">21720721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DMA (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827877</ArticleId><ArticleId IdType="pubmed">17579875</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M (2006) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59:952&#x2013;962</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2629792</ArticleId><ArticleId IdType="pubmed">16718704</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM (1988) Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 93:197&#x2013;203</Citation><ArticleIdList><ArticleId IdType="pubmed">2853844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe J, Lennox G, Jefferson D, Morrell K, McQuire D, Gray T, Landon M, Doherty FJ, Mayer RJ (1988) A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett 94:203&#x2013;210</Citation><ArticleIdList><ArticleId IdType="pubmed">2853853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">1376881</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Murakami N, Kusaka H, Yoshida M, Hashizume Y, Nakazato Y, Matsubara E, Hirai S (1992) Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239:426&#x2013;430</Citation><ArticleIdList><ArticleId IdType="pubmed">1333007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5:339&#x2013;350</Citation><ArticleIdList><ArticleId IdType="pubmed">9117546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolnay M, Probst A (1995) Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492&#x2013;497</Citation><ArticleIdList><ArticleId IdType="pubmed">8745238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton AM, White CL 3rd, Bigio EH (2004) Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 108:379&#x2013;385</Citation><ArticleIdList><ArticleId IdType="pubmed">15351890</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL (2005) Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 62:925&#x2013;930</Citation><ArticleIdList><ArticleId IdType="pubmed">15956163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56:399&#x2013;406</Citation><ArticleIdList><ArticleId IdType="pubmed">15349867</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, Khan N, Al-Sarraj S, Revesz T (2004) Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 30:369&#x2013;373</Citation><ArticleIdList><ArticleId IdType="pubmed">15305982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Shaw CL, Du Plessis D, Richardson AMT, Bailey KL, Julien C, Stopford C, Thompson J, Varma A, Craufurd D, Tian J, Pickering-Brown S, Neary D, Snowden JS, Mann DMA (2005) Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol 110:501&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">16222525</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Mann DM (2000) Classification and description of frontotemporal dementias. Ann N Y Acad Sci 920:46&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">11193176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Shi J, Shaw CL, Duplessis D, Neary D, Snowden JS, Mann DM (2006) Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 112:551&#x2013;559</Citation><ArticleIdList><ArticleId IdType="pubmed">16900341</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Jones AG, Dickson DW (2004) Hippocampal sclerosis and ubiquitin-positive inclusions in dementia lacking distinctive histopathology. Dement Geriatr Cogn Disord 17:342&#x2013;345</Citation><ArticleIdList><ArticleId IdType="pubmed">15178950</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano I (2000) Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 20:68&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">10935441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Feldman H (2003) The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol 105:98&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">12536219</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Knopman DS, Whitwell JL, Boeve BF, Parisi JE, Petersen RC, Dickson DW (2005) Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 65:645&#x2013;647</Citation><ArticleIdList><ArticleId IdType="pubmed">16116138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DM (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 112:539&#x2013;549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668618</ArticleId><ArticleId IdType="pubmed">17021754</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, Bruce J, Grossman M, Trojanowski JQ, Lee VM (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169:1343&#x2013;1352</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1780184</ArticleId><ArticleId IdType="pubmed">17003490</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916&#x2013;919</Citation><ArticleIdList><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW (2007) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66:142&#x2013;151</Citation><ArticleIdList><ArticleId IdType="pubmed">17278999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH (2006) The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129:3081&#x2013;3090</Citation><ArticleIdList><ArticleId IdType="pubmed">17071926</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, Mitchell JE, Habgood JJ, de Belleroche J, Xi J, Jongjaroenprasert W, Horvitz HR, Gunnarsson LG, Brown RH Jr. (2006) A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66:839&#x2013;844</Citation><ArticleIdList><ArticleId IdType="pubmed">16421333</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, Siddique T, Schelhaas HJ, Kusters B, Troost D, Baas F, de Jong V, Shaw CE (2006) Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2&#x2013;21.3. Brain 129:868&#x2013;876</Citation><ArticleIdList><ArticleId IdType="pubmed">16495328</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestronk A, Smith TW, Tu PH, Watts GD, Markesbery WR, Smith CD, Kimonis VE (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65:571&#x2013;581</Citation><ArticleIdList><ArticleId IdType="pubmed">16783167</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee M, Mackenzie IR (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171:227&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami I, Arai T, Hasegawa M (2019) The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol 138:751&#x2013;770</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800885</ArticleId><ArticleId IdType="pubmed">31555895</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, Snowden JS, Mann DM (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521&#x2013;533</Citation><ArticleIdList><ArticleId IdType="pubmed">17219193</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ, Lee VM (2007) TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol 66:177&#x2013;183</Citation><ArticleIdList><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66:152&#x2013;157</Citation><ArticleIdList><ArticleId IdType="pubmed">17279000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY, White CL 3rd (2008) TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol 67:271&#x2013;279</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635119</ArticleId><ArticleId IdType="pubmed">18379440</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118:349&#x2013;358</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044602</ArticleId><ArticleId IdType="pubmed">19455346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M (2017) Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol 134:79&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">28466142</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M (2020) Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol 139:83&#x2013;98</Citation><ArticleIdList><ArticleId IdType="pubmed">31501924</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorpe JR, Tang H, Atherton J, Cairns NJ (2008) Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy. J Neural Transm (Vienna) 115:1661&#x2013;1671</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789307</ArticleId><ArticleId IdType="pubmed">18974920</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Zhang YJ, Baker M, Rademakers R, Petrucelli L, Dickson DW (2019) C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. Acta Neuropathol Commun 7:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6607585</ArticleId><ArticleId IdType="pubmed">31266542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y, Yoshida M, Hasegawa M (2016) Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep 6:23281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M, McCluskey LF, Trojanowski JQ, Lee VM (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173:182&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM, Trojanowski JQ (2011) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. The Journal of biological chemistry 283:13302&#x2013;13309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y, Duffy JR, Josephs KA (2013) Primary progressive aphasia and apraxia of speech. Semin Neurol 33:342&#x2013;347</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215934</ArticleId><ArticleId IdType="pubmed">24234355</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Josephs KA (2012) Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep 12:715&#x2013;723</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3492940</ArticleId><ArticleId IdType="pubmed">23015371</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL (2019) FTD spectrum: Neuroimaging across the FTD spectrum. Prog Mol Biol Transl Sci 165:187&#x2013;223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153045</ArticleId><ArticleId IdType="pubmed">31481163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, Johnson JK, Weiner MW, Miller BL (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335&#x2013;346</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2362399</ArticleId><ArticleId IdType="pubmed">14991811</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245&#x2013;256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, H&#xf6;ltt&#xe4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#xf2; A, Restagno G, Borghero G, Sabatelli M, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM, Irwin DJ, Van Deerlin VM, Trojanowski JQ (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65&#x2013;78</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi R, Tada M, Shiga A, Toyoshima Y, Konno T, Sato T, Nozaki H, Kato T, Horie M, Shimizu H, Takebayashi H, Onodera O, Nishizawa M, Kakita A, Takahashi H (2016) Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes. Acta Neuropathol Commun 4:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918136</ArticleId><ArticleId IdType="pubmed">27338935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM (2019) The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability. Neurology 92:e1354&#x2013;e1366</Citation><ArticleIdList><ArticleId IdType="pubmed">30770429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Gefen T, Mao Q, Appin C, Kohler M, Walker J, Rademakers R, Rademaker A, Rogalski E, Weintraub S, Geula C, Mesulam MM, Bigio EH (2019) Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes. Acta Neuropathol 138:167&#x2013;169</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186909</ArticleId><ArticleId IdType="pubmed">31065833</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Lee EB, Mackenzie IR (2021) Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance. Adv Exp Med Biol 1281:201&#x2013;217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183578</ArticleId><ArticleId IdType="pubmed">33433877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer W (1880) Erkrankung des Ammonshornes als aetiologisches Moment der Epilepsie [Disease of the Ammon&#x2019;s horn as an etiological element of epilepsy]. Arch Psychiatr Nervenkr 10:361&#x2013; 375</Citation></Reference><Reference><Citation>Thom M (2009) Hippocampal sclerosis: progress since Sommer. Brain Pathol 19:565&#x2013;572</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094764</ArticleId><ArticleId IdType="pubmed">18761661</ArticleId></ArticleIdList></Reference><Reference><Citation>Crystal HA, Dickson DW, Sliwinski MJ, Lipton RB, Grober E, Marks-Nelson H, Antis P (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 34:566&#x2013;573</Citation><ArticleIdList><ArticleId IdType="pubmed">8215244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (&gt; or = 80 years of age) humans. Acta Neuropathol 88:212&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">7810292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old humans. Acta Neuropathol 88:599.</Citation><ArticleIdList><ArticleId IdType="pubmed">7879610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ala TA, Beh GO, Frey WH, 2nd (2000) Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer&#x2019;s disease. Neurology 54:843&#x2013;848</Citation><ArticleIdList><ArticleId IdType="pubmed">10690974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger K (2000) Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer&#x2019;s disease. Neurology 55:739&#x2013;740</Citation><ArticleIdList><ArticleId IdType="pubmed">10980757</ArticleId></ArticleIdList></Reference><Reference><Citation>Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D, DiGiacomo L, Bowen JD, McCormick WC, Teri L, Raskind MA, Kukull WA, Larson EB (2002) Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 59:1099&#x2013;1106</Citation><ArticleIdList><ArticleId IdType="pubmed">12117357</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey-Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ (1997) Hippocampal sclerosis contributes to dementia in the elderly. Neurology 48:154&#x2013;160</Citation><ArticleIdList><ArticleId IdType="pubmed">9008511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10:180&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">8939276</ArticleId></ArticleIdList></Reference><Reference><Citation>Blass DM, Hatanpaa KJ, Brandt J, Rao V, Steinberg M, Troncoso JC, Rabins PV (2004) Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology 63:492&#x2013;497</Citation><ArticleIdList><ArticleId IdType="pubmed">15304580</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoshima Y, Piao YS, Tan CF, Morita M, Tanaka M, Oyanagi K, Okamoto K, Takahashi H (2003) Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia. Acta Neuropathol 106:50&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pubmed">12669241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanpaa KJ, Blass DM, Pletnikova O, Crain BJ, Bigio EH, Hedreen JC, White CL 3rd, Troncoso JC (2004) Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 63:538&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">15304590</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16:203&#x2013;212</Citation><ArticleIdList><ArticleId IdType="pubmed">12468894</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW (2006) Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 63:506&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">16606762</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Dickson DW (2007) Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging 28:1718&#x2013;1722</Citation><ArticleIdList><ArticleId IdType="pubmed">16930776</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW (2006) Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 63:1632&#x2013;1638</Citation><ArticleIdList><ArticleId IdType="pubmed">17101834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipps CM, Hodges JR, Hornberger M (2010) Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the &#x2018;bvFTD phenocopy syndrome&#x2019;. Curr Opin Neurol 23:628&#x2013;632</Citation><ArticleIdList><ArticleId IdType="pubmed">20962637</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C, Ahmed Z, Zehr C, Dickson DW (2007) Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol 113:245&#x2013;252</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794627</ArticleId><ArticleId IdType="pubmed">17195931</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer&#x2019;s disease. Ann Neurol 61:435&#x2013;445</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, Parisi JE, Revesz T, Saito Y, Vonsattel JP, Whitwell JL, Wisniewski T, Hu W (2019) LATE to the PART-y. Brain 142:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6736234</ArticleId><ArticleId IdType="pubmed">31359030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wider C, Dickson DW, Stoessl AJ, Tsuboi Y, Chapon F, Gutmann L, Lechevalier B, Calne DB, Personett DA, Hulihan M, Kachergus J, Rademakers R, Baker MC, Grantier LL, Sujith OK, Brown L, Calne S, Farrer MJ, Wszolek ZK (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15:281&#x2013;286</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693935</ArticleId><ArticleId IdType="pubmed">18723384</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2901929</ArticleId><ArticleId IdType="pubmed">20512649</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Wszolek ZK, Rademakers R, Dickson DW (2017) Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy. Mov Disord 32:246&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5933946</ArticleId><ArticleId IdType="pubmed">28009087</ArticleId></ArticleIdList></Reference><Reference><Citation>Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555&#x2013;564</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659339</ArticleId><ArticleId IdType="pubmed">18520774</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW (2018) Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol 136:389&#x2013;404</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309287</ArticleId><ArticleId IdType="pubmed">29926172</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman SH, Spires-Jones T, Hyman BT, Growdon JH, Frosch MP (2008) TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol 67:62&#x2013;67</Citation><ArticleIdList><ArticleId IdType="pubmed">18091558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, Yamazaki M, Oyanagi K (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130:1386&#x2013;1394</Citation><ArticleIdList><ArticleId IdType="pubmed">17439983</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, Perl DP, Hedley-Whyte ET, Price B, Sullivan C, Morin P, Lee HS, Kubilus CA, Daneshvar DH, Wulff M, Budson AE (2010) TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69:918&#x2013;929</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Dickson DW (2017) Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol 133:705&#x2013;715</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091858</ArticleId><ArticleId IdType="pubmed">28160067</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H (2009) Phosphorylated TDP-43 in Alzheimer&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol 117:125&#x2013;136</Citation><ArticleIdList><ArticleId IdType="pubmed">19139911</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67:1159&#x2013;1165</Citation><ArticleIdList><ArticleId IdType="pubmed">19018245</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, Yamada M, Toyoshima Y, Yokoseki A, Miki Y, Hoshi Y, Kaneko H, Ikeuchi T, Onodera O, Kakita A, Takahashi H (2009) Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol 118:553&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pubmed">19526244</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoshima Y, Tanaka H, Shimohata M, Kimura K, Morita T, Kakita A, Takahashi H (2011) Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 122:375&#x2013;378</Citation><ArticleIdList><ArticleId IdType="pubmed">21830155</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AC, Dugger BN, Dickson DW, Wang DS (2011) TDP-43 in aging and Alzheimer&#x2019;s disease - a review. Int J Clin Exp Pathol 4:147&#x2013;155</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037200</ArticleId><ArticleId IdType="pubmed">21326809</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold SJ, Dugger BN, Beach TG (2013) TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol 126:51&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691299</ArticleId><ArticleId IdType="pubmed">23604587</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer A (1906) &#xdc;ber einen eigenartigen schweren Erkrankungsproze&#x3b2; der Hirnrincle [About a peculiar severe disease process of the cerebral cortex]. Neurol Central 25:1129&#x2013;1136</Citation></Reference><Reference><Citation>Hippius H, Neund&#xf6;rfer G (2003) The discovery of Alzheimer&#x2019;s disease. Dialogues Clin Neurosci 5:101&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181715</ArticleId><ArticleId IdType="pubmed">22034141</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement 7:263&#x2013;269</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, van den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15:1182&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Spina S, Miller BL (2017) Frontotemporal Dementia. Neurol Clin 35:339&#x2013;374</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM (2011) The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 134:2478&#x2013;2492</Citation><ArticleIdList><ArticleId IdType="pubmed">21840888</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW (1998) Pick&#x2019;s disease: a modern approach. Brain Pathol 8:339&#x2013;354</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098155</ArticleId><ArticleId IdType="pubmed">9546291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease. Alzheimers Dement 8:1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3266529</ArticleId><ArticleId IdType="pubmed">22265587</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on A, Alzheimer&#x2019;s A (2012) National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease: a practical approach. Acta Neuropathol 123:1&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268003</ArticleId><ArticleId IdType="pubmed">22101365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>